0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cell and Gene Therapy Tools and Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-14Z13658
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell and Gene Therapy Tools and Reagents Market Research Report 2023
BUY CHAPTERS

Cell and Gene Therapy Tools and Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14Z13658
Report
November 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell and Gene Therapy Tools and Reagents - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cell and Gene Therapy Tools and Reagents - Market

Cell and Gene Therapy Tools and Reagents - Market

The global market for Cell and Gene Therapy Tools and Reagents was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Tools and Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell and Gene Therapy Tools and Reagents by region & country, by Type, and by Application.
The Cell and Gene Therapy Tools and Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Tools and Reagents.
Market Segmentation

Scope of Cell and Gene Therapy Tools and Reagents - Market Report

Report Metric Details
Report Name Cell and Gene Therapy Tools and Reagents - Market
CAGR 5%
Segment by Type:
  • Chemiluminescent Immunoassays (CLIA)
  • Fluoroimmunoassay
  • Multiplex Assays
  • Rapid Diagnostic Technologies
Segment by Application
  • Hospitals
  • Laboratories
  • Phamacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ATHERSYS INC., AVROBIO, BIO-RAD LABORATORIES, BIO-TECHNE, CELLGENIX, MESOBLAST LTD., ORGANICELL, QUANTERIX, STEMCELL TECHNOLOGIES, THERMO FISHER, LUMINEX CORP.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Cell and Gene Therapy Tools and Reagents manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Cell and Gene Therapy Tools and Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Cell and Gene Therapy Tools and Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Cell and Gene Therapy Tools and Reagents - Market report?

Ans: The main players in the Cell and Gene Therapy Tools and Reagents - Market are ATHERSYS INC., AVROBIO, BIO-RAD LABORATORIES, BIO-TECHNE, CELLGENIX, MESOBLAST LTD., ORGANICELL, QUANTERIX, STEMCELL TECHNOLOGIES, THERMO FISHER, LUMINEX CORP.

What are the Application segmentation covered in the Cell and Gene Therapy Tools and Reagents - Market report?

Ans: The Applications covered in the Cell and Gene Therapy Tools and Reagents - Market report are Hospitals, Laboratories, Phamacy

What are the Type segmentation covered in the Cell and Gene Therapy Tools and Reagents - Market report?

Ans: The Types covered in the Cell and Gene Therapy Tools and Reagents - Market report are Chemiluminescent Immunoassays (CLIA), Fluoroimmunoassay, Multiplex Assays, Rapid Diagnostic Technologies

1 Market Overview
1.1 Cell and Gene Therapy Tools and Reagents Product Introduction
1.2 Global Cell and Gene Therapy Tools and Reagents Market Size Forecast
1.3 Cell and Gene Therapy Tools and Reagents Market Trends & Drivers
1.3.1 Cell and Gene Therapy Tools and Reagents Industry Trends
1.3.2 Cell and Gene Therapy Tools and Reagents Market Drivers & Opportunity
1.3.3 Cell and Gene Therapy Tools and Reagents Market Challenges
1.3.4 Cell and Gene Therapy Tools and Reagents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell and Gene Therapy Tools and Reagents Players Revenue Ranking (2023)
2.2 Global Cell and Gene Therapy Tools and Reagents Revenue by Company (2019-2024)
2.3 Key Companies Cell and Gene Therapy Tools and Reagents Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell and Gene Therapy Tools and Reagents Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell and Gene Therapy Tools and Reagents
2.6 Cell and Gene Therapy Tools and Reagents Market Competitive Analysis
2.6.1 Cell and Gene Therapy Tools and Reagents Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cell and Gene Therapy Tools and Reagents Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Tools and Reagents as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemiluminescent Immunoassays (CLIA)
3.1.2 Fluoroimmunoassay
3.1.3 Multiplex Assays
3.1.4 Rapid Diagnostic Technologies
3.2 Global Cell and Gene Therapy Tools and Reagents Sales Value by Type
3.2.1 Global Cell and Gene Therapy Tools and Reagents Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cell and Gene Therapy Tools and Reagents Sales Value, by Type (2019-2030)
3.2.3 Global Cell and Gene Therapy Tools and Reagents Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Phamacy
4.2 Global Cell and Gene Therapy Tools and Reagents Sales Value by Application
4.2.1 Global Cell and Gene Therapy Tools and Reagents Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cell and Gene Therapy Tools and Reagents Sales Value, by Application (2019-2030)
4.2.3 Global Cell and Gene Therapy Tools and Reagents Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cell and Gene Therapy Tools and Reagents Sales Value by Region
5.1.1 Global Cell and Gene Therapy Tools and Reagents Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (2019-2024)
5.1.3 Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (2025-2030)
5.1.4 Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
5.2.2 North America Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
5.3.2 Europe Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
5.4.2 Asia Pacific Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
5.5.2 South America Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
5.6.2 Middle East & Africa Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell and Gene Therapy Tools and Reagents Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cell and Gene Therapy Tools and Reagents Sales Value
6.3 United States
6.3.1 United States Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.3.2 United States Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.4.2 Europe Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.5.2 China Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.6.2 Japan Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.7.2 South Korea Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.8.2 Southeast Asia Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cell and Gene Therapy Tools and Reagents Sales Value, 2019-2030
6.9.2 India Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cell and Gene Therapy Tools and Reagents Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 ATHERSYS INC.
7.1.1 ATHERSYS INC. Profile
7.1.2 ATHERSYS INC. Main Business
7.1.3 ATHERSYS INC. Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.1.4 ATHERSYS INC. Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.1.5 ATHERSYS INC. Recent Developments
7.2 AVROBIO
7.2.1 AVROBIO Profile
7.2.2 AVROBIO Main Business
7.2.3 AVROBIO Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.2.4 AVROBIO Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.2.5 AVROBIO Recent Developments
7.3 BIO-RAD LABORATORIES
7.3.1 BIO-RAD LABORATORIES Profile
7.3.2 BIO-RAD LABORATORIES Main Business
7.3.3 BIO-RAD LABORATORIES Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.3.4 BIO-RAD LABORATORIES Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.3.5 BIO-TECHNE Recent Developments
7.4 BIO-TECHNE
7.4.1 BIO-TECHNE Profile
7.4.2 BIO-TECHNE Main Business
7.4.3 BIO-TECHNE Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.4.4 BIO-TECHNE Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.4.5 BIO-TECHNE Recent Developments
7.5 CELLGENIX
7.5.1 CELLGENIX Profile
7.5.2 CELLGENIX Main Business
7.5.3 CELLGENIX Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.5.4 CELLGENIX Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.5.5 CELLGENIX Recent Developments
7.6 MESOBLAST LTD.
7.6.1 MESOBLAST LTD. Profile
7.6.2 MESOBLAST LTD. Main Business
7.6.3 MESOBLAST LTD. Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.6.4 MESOBLAST LTD. Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.6.5 MESOBLAST LTD. Recent Developments
7.7 ORGANICELL
7.7.1 ORGANICELL Profile
7.7.2 ORGANICELL Main Business
7.7.3 ORGANICELL Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.7.4 ORGANICELL Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.7.5 ORGANICELL Recent Developments
7.8 QUANTERIX
7.8.1 QUANTERIX Profile
7.8.2 QUANTERIX Main Business
7.8.3 QUANTERIX Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.8.4 QUANTERIX Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.8.5 QUANTERIX Recent Developments
7.9 STEMCELL TECHNOLOGIES
7.9.1 STEMCELL TECHNOLOGIES Profile
7.9.2 STEMCELL TECHNOLOGIES Main Business
7.9.3 STEMCELL TECHNOLOGIES Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.9.4 STEMCELL TECHNOLOGIES Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.9.5 STEMCELL TECHNOLOGIES Recent Developments
7.10 THERMO FISHER
7.10.1 THERMO FISHER Profile
7.10.2 THERMO FISHER Main Business
7.10.3 THERMO FISHER Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.10.4 THERMO FISHER Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.10.5 THERMO FISHER Recent Developments
7.11 LUMINEX CORP.
7.11.1 LUMINEX CORP. Profile
7.11.2 LUMINEX CORP. Main Business
7.11.3 LUMINEX CORP. Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
7.11.4 LUMINEX CORP. Cell and Gene Therapy Tools and Reagents Revenue (US$ Million) & (2019-2024)
7.11.5 LUMINEX CORP. Recent Developments
8 Industry Chain Analysis
8.1 Cell and Gene Therapy Tools and Reagents Industrial Chain
8.2 Cell and Gene Therapy Tools and Reagents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell and Gene Therapy Tools and Reagents Sales Model
8.5.2 Sales Channel
8.5.3 Cell and Gene Therapy Tools and Reagents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Cell and Gene Therapy Tools and Reagents Market Trends
    Table 2. Cell and Gene Therapy Tools and Reagents Market Drivers & Opportunity
    Table 3. Cell and Gene Therapy Tools and Reagents Market Challenges
    Table 4. Cell and Gene Therapy Tools and Reagents Market Restraints
    Table 5. Global Cell and Gene Therapy Tools and Reagents Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Cell and Gene Therapy Tools and Reagents Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Cell and Gene Therapy Tools and Reagents Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Cell and Gene Therapy Tools and Reagents Product Type
    Table 9. Key Companies Time to Begin Mass Production of Cell and Gene Therapy Tools and Reagents
    Table 10. Global Cell and Gene Therapy Tools and Reagents Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Tools and Reagents as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Cell and Gene Therapy Tools and Reagents Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Cell and Gene Therapy Tools and Reagents Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Cell and Gene Therapy Tools and Reagents Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Cell and Gene Therapy Tools and Reagents Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Cell and Gene Therapy Tools and Reagents Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Cell and Gene Therapy Tools and Reagents Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Cell and Gene Therapy Tools and Reagents Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Cell and Gene Therapy Tools and Reagents Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Cell and Gene Therapy Tools and Reagents Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Cell and Gene Therapy Tools and Reagents Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Cell and Gene Therapy Tools and Reagents Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (2019-2024) & (%)
    Table 27. Global Cell and Gene Therapy Tools and Reagents Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Cell and Gene Therapy Tools and Reagents Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Cell and Gene Therapy Tools and Reagents Sales Value, (2025-2030) & (US$ Million)
    Table 31. ATHERSYS INC. Basic Information List
    Table 32. ATHERSYS INC. Description and Business Overview
    Table 33. ATHERSYS INC. Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of ATHERSYS INC. (2019-2024)
    Table 35. ATHERSYS INC. Recent Developments
    Table 36. AVROBIO Basic Information List
    Table 37. AVROBIO Description and Business Overview
    Table 38. AVROBIO Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of AVROBIO (2019-2024)
    Table 40. AVROBIO Recent Developments
    Table 41. BIO-RAD LABORATORIES Basic Information List
    Table 42. BIO-RAD LABORATORIES Description and Business Overview
    Table 43. BIO-RAD LABORATORIES Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of BIO-RAD LABORATORIES (2019-2024)
    Table 45. BIO-RAD LABORATORIES Recent Developments
    Table 46. BIO-TECHNE Basic Information List
    Table 47. BIO-TECHNE Description and Business Overview
    Table 48. BIO-TECHNE Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of BIO-TECHNE (2019-2024)
    Table 50. BIO-TECHNE Recent Developments
    Table 51. CELLGENIX Basic Information List
    Table 52. CELLGENIX Description and Business Overview
    Table 53. CELLGENIX Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of CELLGENIX (2019-2024)
    Table 55. CELLGENIX Recent Developments
    Table 56. MESOBLAST LTD. Basic Information List
    Table 57. MESOBLAST LTD. Description and Business Overview
    Table 58. MESOBLAST LTD. Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of MESOBLAST LTD. (2019-2024)
    Table 60. MESOBLAST LTD. Recent Developments
    Table 61. ORGANICELL Basic Information List
    Table 62. ORGANICELL Description and Business Overview
    Table 63. ORGANICELL Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of ORGANICELL (2019-2024)
    Table 65. ORGANICELL Recent Developments
    Table 66. QUANTERIX Basic Information List
    Table 67. QUANTERIX Description and Business Overview
    Table 68. QUANTERIX Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of QUANTERIX (2019-2024)
    Table 70. QUANTERIX Recent Developments
    Table 71. STEMCELL TECHNOLOGIES Basic Information List
    Table 72. STEMCELL TECHNOLOGIES Description and Business Overview
    Table 73. STEMCELL TECHNOLOGIES Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of STEMCELL TECHNOLOGIES (2019-2024)
    Table 75. STEMCELL TECHNOLOGIES Recent Developments
    Table 76. THERMO FISHER Basic Information List
    Table 77. THERMO FISHER Description and Business Overview
    Table 78. THERMO FISHER Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of THERMO FISHER (2019-2024)
    Table 80. THERMO FISHER Recent Developments
    Table 81. LUMINEX CORP. Basic Information List
    Table 82. LUMINEX CORP. Description and Business Overview
    Table 83. LUMINEX CORP. Cell and Gene Therapy Tools and Reagents Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Cell and Gene Therapy Tools and Reagents Business of LUMINEX CORP. (2019-2024)
    Table 85. LUMINEX CORP. Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Cell and Gene Therapy Tools and Reagents Downstream Customers
    Table 89. Cell and Gene Therapy Tools and Reagents Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Cell and Gene Therapy Tools and Reagents Product Picture
    Figure 2. Global Cell and Gene Therapy Tools and Reagents Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cell and Gene Therapy Tools and Reagents Sales Value (2019-2030) & (US$ Million)
    Figure 4. Cell and Gene Therapy Tools and Reagents Report Years Considered
    Figure 5. Global Cell and Gene Therapy Tools and Reagents Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cell and Gene Therapy Tools and Reagents Revenue in 2023
    Figure 7. Cell and Gene Therapy Tools and Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chemiluminescent Immunoassays (CLIA) Picture
    Figure 9. Fluoroimmunoassay Picture
    Figure 10. Multiplex Assays Picture
    Figure 11. Rapid Diagnostic Technologies Picture
    Figure 12. Global Cell and Gene Therapy Tools and Reagents Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Cell and Gene Therapy Tools and Reagents Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Laboratories
    Figure 16. Product Picture of Phamacy
    Figure 17. Global Cell and Gene Therapy Tools and Reagents Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Cell and Gene Therapy Tools and Reagents Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Cell and Gene Therapy Tools and Reagents Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Cell and Gene Therapy Tools and Reagents Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Cell and Gene Therapy Tools and Reagents Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Cell and Gene Therapy Tools and Reagents Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Cell and Gene Therapy Tools and Reagents Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Cell and Gene Therapy Tools and Reagents Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Cell and Gene Therapy Tools and Reagents Sales Value (%), (2019-2030)
    Figure 30. United States Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Cell and Gene Therapy Tools and Reagents Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Cell and Gene Therapy Tools and Reagents Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Cell and Gene Therapy Tools and Reagents Sales Value by Application (%), 2023 VS 2030
    Figure 51. Cell and Gene Therapy Tools and Reagents Industrial Chain
    Figure 52. Cell and Gene Therapy Tools and Reagents Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Z18292
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14Z15017
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7M18883
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37J14968
Thu Dec 12 00:00:00 UTC 2024

Add to Cart